The US Court of Appeals for the Fifth Circuit explained that ordinarily, when state law contradicts with federal law, the state law may be preempted by the federal law under the US Constitution’s Supremacy Clause. However,...more
5/8/2025
/ Appeals ,
Constitutional Challenges ,
Drug Compounding ,
FDA Approval ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Pharmaceutical Industry ,
Preemption ,
Prescription Drugs ,
State and Local Government ,
Supremacy Clause ,
Unfair Competition
The US Court of Appeals for the Federal Circuit affirmed a district court decision rejecting claims of a patent application directed to a dosing regimen for a cancer treatment, finding the claims to be obvious where the...more
3/13/2025
/ Appeals ,
Healthcare ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Inventors ,
Life Sciences ,
Motivation to Combine ,
Obviousness ,
Patent Applications ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents